197 Acyl-CoA binding protein-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 5 | 7.7 | 0.65× | q = 0.28 | |
| Lipids and lipid-like molecules | 7 | 1.8 | 3.98× | not tested | |
| Organic nitrogen compounds | 2 | 0.5 | 3.97× | not tested | |
| Nucleosides, nucleotides, and analogues | 6 | 4.4 | 1.38× | not tested | |
| Homogeneous non-metal compounds | 4 | 3.4 | 1.18× | not tested | |
| Benzenoids | 1 | 1.2 | 0.87× | not tested | |
| Organic acids and derivatives | 2 | 2.4 | 0.82× | not tested | |
| Organoheterocyclic compounds | 1 | 2.4 | 0.41× | not tested | |
| Organic oxygen compounds | 1 | 3.1 | 0.32× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01992 | COA | Coenzyme A | 15 |
| DB03193 | STE | Stearic acid | 6 |
| DB03796 | PLM | Palmitic Acid | 4 |
| DB02180 | MYA | Myristoyl-Coa | 2 |
| DB02676 | B3P | 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol | 2 |
| DB12010 | — | Fostamatinib | 2 |
| DB00630 | — | Alendronic acid | 1 |
| DB00891 | SFY | Sulfapyridine | 1 |
| DB01097 | — | — | 1 |
| DB01645 | — | Genistein | 1 |
| DB02806 | MXE | 2-Methoxyethanol | 1 |
| DB03381 | — | — | 1 |
| DB03904 | URE | Urea | 1 |
| DB07460 | — | 2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE | 1 |
| DB08231 | MYR | Myristic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| COA | COENZYME A | 14 |
| ST9 | STEAROYL-COENZYME A | 6 |
| STE | STEARIC ACID | 6 |
| PLM | PALMITIC ACID | 4 |
| ZNmetal | ZINC ION | 4 |
| UNX | UNKNOWN ATOM OR ION | 3 |
| B3P | 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL | 2 |
| BR | BROMIDE ION | 2 |
| CL | CHLORIDE ION | 2 |
| MYA | TETRADECANOYL-COA | 2 |
| AWD | ~{N}-(4-fluorophenyl)-4-methyl-piperazine-1-carboxamide | 1 |
| CDmetal | CADMIUM ION | 1 |
| H0D | N-(4-chlorophenyl)-N'-[(2R)-1-hydroxybutan-2-yl]urea | 1 |
| HGE | ethyl 1-pyrazin-2-ylpiperidine-4-carboxylate | 1 |
| IOD | IODIDE ION | 1 |
| K0A | (2,5-dimethyl-1,3-thiazol-4-yl)(pyrrolidin-1-yl)methanone | 1 |
| MXE | 2-METHOXYETHANOL | 1 |
| MYR | MYRISTIC ACID | 1 |
| NImetal | NICKEL (II) ION | 1 |
| NU4 | 2-methyl-N-(pyridin-4-yl)furan-3-carboxamide | 1 |